Through the proposed reverse takeover and an accompanying financing plan, SVF Vaccines aims to accelerate the development of the company’s innovative therapeutic and prophylactic vaccines based on a ...
Vancouver, British Columbia--(Newsfile Corp. - August 18, 2025) - GoviEx Uranium Inc. (GXU:CA) (OTCQB: GVXXF) ("GoviEx" or the "Company") is pleased to announce that it has today, 18 August 2025, ...
ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NLSP) (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results